Cigarette smoking, nicotine levels and increased risk for metabolic syndrome in women with polycystic ovary syndrome

Gynecological Endocrinology

Volumn 29, Issue 6, 2013, Pages 551-555

  Pau, Cindy Ta ^a   Keefe, Candace C ^a   Welt, Corrine K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cotinine; Hyperandrogenism; Insulin resistance; Testosterone; Triglycerides

Indexed keywords

ANDROGEN; COTININE; NICOTINE; TRIACYLGLYCEROL;

ADULT; ANDROGEN BLOOD LEVEL; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HIGH RISK PATIENT; HUMAN; METABOLIC SYNDROME X; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PULSE RATE; RISK FACTOR; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; METABOLIC SYNDROME X; MIDDLE AGED; NICOTINE; POLYCYSTIC OVARY SYNDROME; PREVALENCE; RISK FACTORS; SMOKING; WAIST-HIP RATIO; YOUNG ADULT;

EID: 84877587323     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2013.788634     Document Type: Article

References (24)

1. Asuncion M, Calvo RM, San Millan JL, et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85: 2434-8
2. Revised 2003. consensus on diagnostic criteria and long-Term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-7
3. Ehrmann DA, Liljenquist DR, Kasza K, et al. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 2005;91: 48-53
4. Ehrmann DA, Barnes RB, Rosenfield RL, et al. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999;22:141-6
5. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999;84: 165-9
6. Bhattacharya SM. Prevalence of metabolic syndrome in women with polycystic ovary syndrome, using two proposed definitions. Gynecol Endocrinol 2010;26:516-20
7. Norman RJ, Davies MJ, Lord J, Moran LJ. The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol Metab 2002;13:251-7
8. Cigarette smoking among adults and trends in smoking cessation -United States, 2008. MMWR Morb Mortal Wkly Rep 2009;58:1227-32
9. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: An analysis of published data. BMJ 1989;298:784-8
10. Barbieri RL, McShane PM, Ryan KJ. Constituents of cigarette smoke inhibit human granulosa cell aromatase. Fertil Steril 1986;46: 232-6
11. Sowers MF, Beebe JL, McConnell D, et al. Testosterone concentrations in women aged 25-50 years: Associations with lifestyle, body composition, and ovarian status. Am J Epidemiol 2001;153: 256-64
12. Welt CK, Arason G, Gudmundsson JA, et al. Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations. J Clin Endocrinol Metab 2006;91:4361-8
13. Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific; 1992:377-84
14. Eskenazi B, Prehn AW, Christianson RE. Passive and active maternal smoking as measured by serum cotinine: The effect on birthweight. Am J Public Health 1995;85:395-8
15. Benowitz NL, Jacob III P. Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers. Clin Pharmacol Ther 1993;53:316-23
16. Howe G, Westhoff C, Vessey M, Yeates D. Effect of age, cigarette smoking and other factors in fertility: Findings in a large prospective study. Br Med J 1985;290:1697-700
17. Grundy SM, Brewer B, Cleeman JI, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/ American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-8
18. Eliasson B, Mero N, Taskinen MR, Smith U. The insulin resistance syndrome and postprandial lipid intolerance in smokers. Atherosclerosis 1997;129:79-88
19. Freeman DJ, Caslake MJ, Griffin BA, et al. The effect of smoking on post-heparin lipoprotein and hepatic lipase, cholesteryl ester transfer protein and lecithin:cholesterol acyl transferase activities in human plasma. Eur J Clin Invest 1998;28:584-91
20. Griffin BA, Freeman DJ, Tait GW, et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: Relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 1994;106:241-53
21. Cupisti S, Haberle L, Dittrich R, et al. Smoking is associated with increased free testosterone and fasting insulin levels in women with polycystic ovary syndrome, resulting in aggravated insulin resistance. Fertil Steril 2010;94:673-7
22. Shimokata H, Muller DC, Andres R. Studies in the distribution of body fat. III. Effects of cigarette smoking. JAMA 1989;261:1169-73
23. Kong C, Nimmo L, Elatrozy T, et al. Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in type 2 diabetes. Atherosclerosis 2001; 156:373-8
24. Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smokingassociated hemodynamic and metabolic events. N Engl J Med 1976; 295:573-7